GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

teclistamab   Click here for help

GtoPdb Ligand ID: 12233

Synonyms: JNJ-64007957 | teclistamab-cqyv | Tecvayli®
Approved drug
teclistamab is an approved drug (EMA & FDA (2022))
Compound class: Antibody
Comment: Teclistamab (JNJ-64007957) is a bispecific IgG4 monoclonal antibody that simultaneously engages CD3 on the surface of T cells, and B-cell maturation antigen (BCMA) that is expressed on the surface of multiple myeloma (MM) cells, to induce a T cell-mediated cytotoxic immune response against the BCMA +ve cells [2].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2024)  |  EU EMA (2022)  |  US FDA (2022)
International Nonproprietary Names Click here for help
INN number INN
10928 teclistamab
Synonyms Click here for help
JNJ-64007957 | teclistamab-cqyv | Tecvayli®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 894
Other databases
GtoPdb PubChem SID 473153821
Search PubMed clinical trials teclistamab
Search PubMed titles teclistamab
Search PubMed titles/abstracts teclistamab